These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


314 related items for PubMed ID: 300468

  • 1. Von Willebrand's disease: combined qualitative and quantitative abnormalities.
    Gralnick HR, Sultan Y, Coller BS.
    N Engl J Med; 1977 May 05; 296(18):1024-30. PubMed ID: 300468
    [Abstract] [Full Text] [Related]

  • 2. Heterogeneous abnormalities in the multimeric structure, antigenic properties, and plasma-platelet content of factor VIII/von Willebrand factor in subtypes of classic (type I) and variant (type IIA) von Willebrand's disease.
    Weiss HJ, Pietu G, Rabinowitz R, Girma JP, Rogers J, Meyer D.
    J Lab Clin Med; 1983 Mar 05; 101(3):411-25. PubMed ID: 6186757
    [Abstract] [Full Text] [Related]

  • 3. Studies of the human factor VIII/von Willebrand factor protein. III. Qualitative defects in von Willebrand's disease.
    Gralnick HR, Coller BS, Sultan Y.
    J Clin Invest; 1975 Oct 05; 56(4):814-27. PubMed ID: 1080491
    [Abstract] [Full Text] [Related]

  • 4. Carbohydrate of the factor VIII/von Willebrand factor in von Willebrand's disease.
    Zimmerman TS, Voss R, Edgington TS.
    J Clin Invest; 1979 Nov 05; 64(5):1298-302. PubMed ID: 315413
    [Abstract] [Full Text] [Related]

  • 5. Acquired von Willebrand's disease. Evidence for a quantitative and qualitative factor VIII disorder.
    Joist JH, Cowan JF, Zimmerman TS.
    N Engl J Med; 1978 May 04; 298(18):988-91. PubMed ID: 306064
    [Abstract] [Full Text] [Related]

  • 6. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.
    Weiss HJ, Hoyer LW, Rickles FR, Varma A, Rogers J.
    J Clin Invest; 1973 Nov 04; 52(11):2708-16. PubMed ID: 4542944
    [Abstract] [Full Text] [Related]

  • 7. The factor VIII abnormality in severe von Willebrand's disease.
    Zimmerman TS, Abildgaard CF, Meyer D.
    N Engl J Med; 1979 Dec 13; 301(24):1307-10. PubMed ID: 315519
    [Abstract] [Full Text] [Related]

  • 8. Stabilization of factor VIII in plasma by the von Willebrand factor. Studies on posttransfusion and dissociated factor VIII and in patients with von Willebrand's disease.
    Weiss HJ, Sussman II, Hoyer LW.
    J Clin Invest; 1977 Aug 13; 60(2):390-404. PubMed ID: 17621
    [Abstract] [Full Text] [Related]

  • 9. Pathophysiology of von Willebrand's disease: Qualitative and quantitative analysis of von Willebrand protein.
    Fukui H, Yoshioka A, Mikami S, Takase T, Fujimura Y, Takahashi Y, Nishino M, Iwagaki K.
    Nihon Ketsueki Gakkai Zasshi; 1979 Dec 13; 42(6):839-50. PubMed ID: 121660
    [No Abstract] [Full Text] [Related]

  • 10. Gel filtration patterns of factor VIII coagulant antigen and factor VIII related antigen in normal and von Willebrand's disease.
    Chediak J, Peake I, Bloom A.
    Thromb Haemost; 1983 Aug 30; 50(2):509-12. PubMed ID: 6415844
    [Abstract] [Full Text] [Related]

  • 11. Electrophoretic heterogeneity of normal factor VIII/Von Willebrand protein, and abnormal electrophoretic mobility in patients with Von Willebrand's disease.
    Sultan Y, Simeon J, Caen JP.
    J Lab Clin Med; 1976 Feb 30; 87(2):185-94. PubMed ID: 1082003
    [Abstract] [Full Text] [Related]

  • 12. [Von Willebrand's syndrome (author's transl)].
    Larrieu MJ, Meyer D, Ardaillou N.
    Nouv Rev Fr Hematol Blood Cells; 1977 Feb 30; 18(2):371-82. PubMed ID: 303357
    [Abstract] [Full Text] [Related]

  • 13. Heterogeneity of molecular size of factor VIII/von Willebrand factor in von Willbrand's disease.
    Mikami S, Takahashi Y, Nishino M, Okubo Y, Fukui H.
    Thromb Haemost; 1981 Jun 30; 45(3):272-5. PubMed ID: 6792740
    [Abstract] [Full Text] [Related]

  • 14. The effects of epinephrine infusion in patients with von Willebrand's disease.
    Rickles FR, Hoyer LW, Rick ME, Ahr DJ.
    J Clin Invest; 1976 Jun 30; 57(6):1618-25. PubMed ID: 1084352
    [Abstract] [Full Text] [Related]

  • 15. Heightened interaction between platelets and factor VIII/von Willebrand factor in a new subtype of von Willebrand's disease.
    Ruggeri ZM, Pareti FI, Mannucci PM, Ciavarella N, Zimmerman TS.
    N Engl J Med; 1980 May 08; 302(19):1047-51. PubMed ID: 6767976
    [Abstract] [Full Text] [Related]

  • 16. von Willebrand's disease antigen II. A new plasma and platelet antigen deficient in severe von Willebrand's disease.
    Montgomery RR, Zimmerman TS.
    J Clin Invest; 1978 Jun 08; 61(6):1498-507. PubMed ID: 307007
    [Abstract] [Full Text] [Related]

  • 17. Heterogeneity of sugar composition of factor VIII/von Willebrand factor in von Willebrand's disease: analysis by crossed affinoimmunoelectrophoresis using lectin (ricinus communis agglutinin-120).
    Mikami S, Ueda M, Yasui M, Takahashi Y, Nishino M, Fukui H.
    Thromb Haemost; 1983 Apr 28; 49(2):87-90. PubMed ID: 6408753
    [Abstract] [Full Text] [Related]

  • 18. Hemophilia and von Willebrand's disease: genetic considerations.
    Green D.
    Ann Clin Lab Sci; 1980 Apr 28; 10(2):123-7. PubMed ID: 6770741
    [Abstract] [Full Text] [Related]

  • 19. Pseudo-von Willebrand's disease. An intrinsic platelet defect with aggregation by unmodified human factor VIII/von Willebrand factor and enhanced adsorption of its high-molecular-weight multimers.
    Weiss HJ, Meyer D, Rabinowitz R, Pietu G, Girma JP, Vicic WJ, Rogers J.
    N Engl J Med; 1982 Feb 11; 306(6):326-33. PubMed ID: 6798442
    [Abstract] [Full Text] [Related]

  • 20. [Sugar-chain of factor VIII/von Willebrand factor in von Willebrand's disease. Analysis by immuno-affinoelectrophoresis using lectin].
    Ueda M, Yasui M, Nishino M, Mikami S, Fukui H.
    Nihon Ketsueki Gakkai Zasshi; 1983 Sep 11; 46(5):1117-23. PubMed ID: 6421045
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.